Valneva Wins $49M Contract to Supply Japanese Encephalitis Vaccine to U.S. Military

Valneva USA Inc.,* Bethesda, Maryland, has been awarded a maximum $49,297,248 firm-fixed-price, indefinite-delivery/indefinite-quantity contract for the Japanese encephalitis virus vaccine. This was a sole-source acquisition using justification 10 U.S. Code 3204 (a)(1), as stated in the Federal Acquisition Regulation 6.302-1. This is a one-year contract with no option periods. Location of performance is Scotland, with a Jan. 28, 2026, ordering period end date. Using customers are Army, Navy, Air Force, Marine Corps, and Coast Guard. Type of appropriation is fiscal 2025 through 2026 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2DP-25-D-0002).